GB Patent

GB2245492A — Programmed release oral solid pharmaceutical dosage form

Assigned to Zambon Group SpA · Expires 1992-01-08 · 34y expired

What this patent protects

An orally administrable programmed release (i.e. release after a predetermined delay) pharmaceutical preparation comprises a core containing the drug. The core is coated with a hydrophobic material (m.p. 50.90 DEG C) and a surfactant (HLB value 10-16). A water-soluble film formin…

USPTO Abstract

An orally administrable programmed release (i.e. release after a predetermined delay) pharmaceutical preparation comprises a core containing the drug. The core is coated with a hydrophobic material (m.p. 50.90 DEG C) and a surfactant (HLB value 10-16). A water-soluble film forming material may also be incorporated into the coating. There may also be an outer coating which may be an enteric coating or a coating of the same or another drug for prompt release.

Drugs covered by this patent

Patent Metadata

Patent number
GB2245492A
Jurisdiction
GB
Classification
—
Expires
1992-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Zambon Group SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.